文献速递细菌感染、耐药与抗菌药物医院感染防控

骨科肿瘤手术手术部位感染负担:PARITY试验二次分析

The Burden of Surgical Site Infections With Pathogens Presumably Resistant to Perioperative Prophylaxis in Orthopedic Tumor Surgery: Secondary Analysis of the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Trial.
PubMed 文献 · J Infect Dis · 2026-01-01

该研究为PARITY试验的二次分析,评估下肢恶性骨肿瘤手术患者手术部位感染(SSI)的微生物学特征及围手术期预防抗生素耐药风险因素。604例患者中96例(15.9%)发生SSI,73例(76.0%)分离出至少一种病原体。

要点

  • SSI发生率15.9%,最常见病原体为凝固酶阴性葡萄球菌、金黄色葡萄球菌和肠杆菌目。
  • 预防抗生素疗程长短未显著影响病原体对头孢菌素的推定耐药比例。
  • 抗生素骨水泥的使用与耐药病原体选择相关。

核心结论

  • 骨科肿瘤重建术后由推定对系统或局部预防药物耐药的病原体引起的SSI常见。
  • 耐药病原体的选择并非由预防抗生素疗程驱动,但抗生素骨水泥与耐药相关。

研究设计与样本

  • PARITY试验的二次分析,评估短期(24小时)与长期(5天)术后预防抗生素对SSI发生率的影响。
  • 共纳入604例患者,其中96例(15.9%)发生SSI,73例(76.0%)分离出至少一种病原体。

主要发现

  • SSI中最常见病原体为凝固酶阴性葡萄球菌(34.4%)、金黄色葡萄球菌(24.0%)和肠杆菌目(22.9%)。

临床怎么用

  • 骨科肿瘤手术患者SSI中耐药病原体常见,应重视围手术期预防策略。
  • 抗生素骨水泥的使用可能与耐药病原体选择相关,需权衡利弊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical procedures for malignant bone tumors of the lower extremity are associated with a significant risk of surgical site infection (SSI). Little is known about the microbiology and risk factors for resistant SSIs in this population. METHODS: We describe the microbiological and other characteristics and of SSIs, as well as risk factors for antimicrobial resistance against antibiotics used for perioperative prophylaxis in a secondary analysis of the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) trial population. The PARITY trial assessed the effects of short-term (24 hour) versus long-term (5-day) postoperative antibiotic prophylaxis on the SSI incidence in orthopedic oncology. RESULTS: SSIs were identified in 96 of 604 patients (15.9%), with ≥1 pathogen isolated in 73 (76.0%). The most common pathogens were coagulase-negative staphylococci (34.4%), Staphylococcus aureus (24.0%), and Enterobacterales (22.9%). The proportions of pathogens with presumed resistance against cephalosporins were similar in the 2 groups (65.9% in the short-term vs 71.9% in the long-term arm; odds ratio [OR], 0.76 [95% confidence interval, .28-2.06]; P = .58). Neutropenia (22.9% vs 4.8%; OR, 5.95 [95% confidence interval, .72-49.45]; P = .06) and initiation of antibiotics >7 days before SSI diagnosis (50.0% vs 34.8%; OR, 1.88 [.68-5.21; P = .22) were numerically but not statistically significantly more common in those with presumed resistance. CONCLUSIONS: SSIs due to pathogens presumably resistant to the systemic or local prophylactic agents used are common in patients undergoing reconstruction for bone tumors. The selection of presumably resistant pathogens is not driven by the duration of antibiotic prophylaxis; however, antibiotic-loaded cement was associated with resistance.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Kuster S, Gottlich C, O'Shea T, et al. The Burden of Surgical Site Infections With Pathogens Presumably Resistant to Perioperative Prophylaxis in Orthopedic Tumor Surgery: Secondary Analysis of the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Trial. J Infect Dis. 2026. PMID: 41051375. doi:10.1093/infdis/jiaf513

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。